Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis | Zendy

Thomas Reinehr | Zendy; Joachim Woelfle | Zendy; Rainer Wunsch | Zendy; Christian L. Roth | Zendy

Open Access

Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis

Author(s) -

Thomas Reinehr,

Joachim Woelfle,

Rainer Wunsch,

Christian L. Roth

Publication year - 2012

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-1221

Subject(s) - medicine , endocrinology , leptin , insulin resistance , fgf21 , body mass index , nonalcoholic fatty liver disease , obesity , metabolic syndrome , fatty liver , weight loss , glucose homeostasis , insulin , waist , fibroblast growth factor , disease , receptor

Fibroblast growth factor 21 (FGF-21), a potent activator of glucose uptake, has been proposed to be related to insulin resistance, metabolic syndrome (MetS), nonalcoholic fatty liver disease (NAFLD), and weight status.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research